Paper25730813
Evaluation of cytotoxicity and antiviral activity of ivermectin against Newcastle disease virus.
Azeem S and 4 others. Pak J Pharm Sci, 2015. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of cytotoxicity and antiviral activity of ivermectin against Newcastle disease virus. Papers, record 25730813. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25730813
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of cytotoxicity and antiviral activity of ivermectin against Newcastle disease virus.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Ivermectin | Major topic |
| Newcastle disease virus | Major topic |
| Animals | |
| Cell Line | |
| Cell Survival | |
| Chick Embryo | |
| Ribavirin |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04551755 | Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19 | Background | ClinicalTrials.gov | |
| NCT04602507 | Ivermectin in Adults With Severe COVID-19. | Background | ClinicalTrials.gov |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42317461 | Ivermectin in veterinary medicine: a narrative review of antiparasitic efficacy, resistance evolution, antiviral evidence, and One Health implications. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/42317461 | PubMed |
| 41874838 | Molecular characterization of virulent genotype XIII Newcastle disease virus isolates from desi-chickens in Namakkal, South India. | Vet Res Commun | 2026 | https://conductscience.org/library/papers/41874838 | PubMed |
| 40006532 | Experimental Investigation into the Design, Optimization, Toxicity, and Anti-Viral Efficacy of Proliposomes Loaded with Ivermectin Against Infectious Bronchitis Virus Using an Embryonated Chicken Egg Model. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40006532 | PubMed |
| 37422646 | Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2. | Virol J | 2023 | https://conductscience.org/library/papers/37422646 | PubMed |
| 35855004 | The Politicization of Ivermectin Tweets During the COVID-19 Pandemic. | Open Forum Infect Dis | 2022 | https://conductscience.org/library/papers/35855004 | PubMed |
| 35382155 | Evaluation of ivermectin antiviral activity against avian infectious bronchitis virus using a chicken embryo model. | Int J Vet Sci Med | 2022 | https://conductscience.org/library/papers/35382155 | PubMed |
| 35359702 | Can anti-parasitic drugs help control COVID-19? | Future Virol | 2022 | https://conductscience.org/library/papers/35359702 | PubMed |
| 34722735 | Regression of bovine cutaneous papillomas via ivermectin-induced immunostimulant and oxidative stress. | J Adv Vet Anim Res | 2021 | https://conductscience.org/library/papers/34722735 | PubMed |
| 34163159 | Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19. | Int J Nanomedicine | 2021 | https://conductscience.org/library/papers/34163159 | PubMed |
| 33713753 | Ivermectin also inhibits the replication of bovine respiratory viruses (BRSV, BPIV-3, BoHV-1, BCoV and BVDV) in vitro. | Virus Res | 2021 | https://conductscience.org/library/papers/33713753 | PubMed |
| 33614709 | Therapeutic Strategies in the Management of COVID-19. | Front Mol Biosci | 2020 | https://conductscience.org/library/papers/33614709 | PubMed |
| 33427370 | A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin's possible mode of action against SARS-CoV-2. | Fundam Clin Pharmacol | 2021 | https://conductscience.org/library/papers/33427370 | PubMed |
| 32837982 | Known drugs and small molecules in the battle for COVID-19 treatment. | Genes Dis | 2020 | https://conductscience.org/library/papers/32837982 | PubMed |
| 32824399 | Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/32824399 | PubMed |
| 32752944 | Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2. | J Biomol Struct Dyn | 2021 | https://conductscience.org/library/papers/32752944 | PubMed |
| 32533071 | Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen. | J Antibiot (Tokyo) | 2020 | https://conductscience.org/library/papers/32533071 | PubMed |
| 32473642 | Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. | Ann Clin Microbiol Antimicrob | 2020 | https://conductscience.org/library/papers/32473642 | PubMed |
| 32322397 | Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance. | New Microbes New Infect | 2020 | https://conductscience.org/library/papers/32322397 | PubMed |
| 28799438 | Structural evaluation of the peritubular sheath of rat's testes after administration of ribavirin: A possible impact on the testicular function. | Int J Immunopathol Pharmacol | 2017 | https://conductscience.org/library/papers/28799438 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25730813
GET https://conductscience.org/api/papers/v1/25730813/authors